Jenny Y. Xue

机构：Memorial Sloan Kettering Cancer Center, University of British Columbia · ORCID：0000-0003-1192-1836

发表论文 54 篇 · 总被引 3902 次 · h-index 14

代表论文

• Pan-KRAS inhibitor disables oncogenic signalling and tumour growth (2023 · Nature · 被引 536)
• In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma (2024 · Cell Reports Medicine · 被引 22)
• Understanding and optimising helmet-related and other health and social effects of the first North American university campus skatepark (2024 · Leisure Studies · 被引 1)
• Data from The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients (2023)
• Supplementary Data from The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients (2023)
• Supplementary Data from The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients (2023)